336040 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
TASCOM Co., Ltd. engages in the research and development of cell therapy products, diabetes management medical devices, and in vitro diagnostic medical devices. Its main product, the SimplexTAS system, is the point-of-care clinical chemistry and immunology simultaneous analysis system that uses capillary blood samples directly and eliminates blood cell interference. The company was founded by Jun-Seop Shin and In-Geun Lee on March 11, 2014 and is headquartered in Anyang-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
336040 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company